Summary
In a retrospective study, paraffin-embedded cystectomy specimens obtained from 46 patients with bladder cancer (stage pT1 — pT4a, pN0, pN2) were analysed for tumor DNA ploidy and proliferation using automated image cytometry (LEYTAS). In 41 cases, DNA ploidy could be measured. Estimation of proliferation was possible in 26 tumors. The number of cells with a DNA content higher than 5C could be calculated in 38 of the tumors. All these three parameters are shown to correlate with patient outcome.
Similar content being viewed by others
References
Bandhauer K, Nemeth Th (1983) Die prognostische Relevanz des primären Differenzierungsgrades und des Erythrozyten-Adhärenz-Testes (SRCA) bei oberflächlichen Blasenkarzinomen. Akt Urol 14:119–122
Bergmann S, Javadpur N (1978) The cell surface antigen A, B or 0(H) as an indicator of malignant potential in stage A bladder carcinoma. J Urol 119:49–51
Coon JS, Schwartz D, Summers JL, Miller AW, Weinstein RS (1986) Flow cytometric analysis of deparaffinized nuclei in urinary bladder carcinoma. Comparison with cytogenetic analysis. Cancer 57:1594–1601
Driel-Kulker AMJV, Mesker WE, Velzen IV, Tanke HJ, Feichtinger J, Ploem JS (1985) Preparation of monolayer smears from paraffinembedded tissue for image cytometry. Cytometry 6:268–272
Driel-Kulker AMJv, Ploem JS (1982) The use of LEYTAS in analytical and quantitative cytology. IEEE transactions on biomedical engineering, vol. BME-29, no 2, pp 92–100
England HR, Paris AMI, Blandy JP (1981) The correlation of T1 bladder tumour history with prognosis and follow-up requirements. Br J Urol 53:593–597
Farsund T, Hoestmark JG, Laerum OD (1984) Relation between flow cytometry DNA distribution and pathology in human bladder cancer. A report of 69 cases. Cancer 54:1771–1777
Gustafson H, Tribukait B, Esposti PL (1982) The prognostic value of DNA analysis in primary carcinoma in situ of the urinary bladder. Scand J Urol Nephrol 16:141–146
Harker WG, Meyers FJ, Freiha FS, Palmer JM, Shortliffe LD, Hannigan JF, McWhirter KM, Torti FM (1985) Cisplatin, methotrexate and vinblastine (CMV): an elective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A northern California oncology group study. J Clin Oncol 3:1463–1470
Harmer MH (1978) TNM classification of malignant tumors, 3rd edn. Union Internationale Contre le Cancer (UICC), Geneva
Hedley DW, Riedlander ML, Taylor IW, Rugg CA, Musgrove EA (1983) Method for analysis of cellular DNA content of paraffinembedded pathological material using flow cytometry. J Histochem Cytochem 31:1333–1335
Heney NM, Proppe K, Prout GR, Griffin PP, Shipley WU (1983) Invasive bladder cancer: Tumour configuration, lymphatic invasion and survival. J Urol 130:895–897
Hope-Stone HF, Oliver RTD, England HR, Blandy JP (1984) T3 bladder cancer: salvage rather than elective surgery after radiotherapy. Urology 24:315–320
Ingen EMv, Verwoerd N, Ploem JS (1980) LEYTAS-2: A hybrid system for the analysis of cytological preparations, using both hardware and software methods. Microscopica Acta [Suppl] 4:73–81
Jacobi GH, Klippel KF, Hohenfellner R (1983) 15 Jahre Erfahrung mit der radikalen Zystektomie ohne präoperative Radiotherapie beim Harnblasenkarzinom. Akt Urol 14:63–69
Jakse G, Rauschmeier H, Lentsch P, Hofstaedter F (1983) Der Tumorinfiltrationstyp. Eine Möglichkeit zur Klassifizierung muskelinfiltrierender Blasentumoren. Akt Urol 14:179–182
Jakse G, Frommhold H, zur Nedden D (1985) Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder. Cancer 55:1659–1664
Jewett HJ (1952) Carcinoma of the bladder: influence of depth of infiltration on the 5 year results following complete exstirpation of the primary growth. J Urol 67:672–676
Jewett HJ, King LR, Shelley WM (1964) A study of 365 cases of infiltrating bladder cancer: relation of certain pathological characteristics to prognosis after exstirpation. J Urol 92:668–678
Ljungberg B, Stenling R, Roos G (1986) Prognostic value of Deoxyribonucleic Acid content in metastatic renal cell carcinoma. J Urol 136:801–804
Lutzeyer W, Ruebben H, Dahm H (1982) Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 127:250–252
Meyer F (1979) Iterative image transformations for automative screening of cervical smears. J Histochem Cytochem 27:128–135
Oljans PJ, Tanke HJ (1986) Flow cytometric analysis of DNA content in bladder cancer: prognostic value of the DNA index with respect to early tumor recurrence in G2 tumours. World J Urol 4:205–210
Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128:34–36
Skinner DG, Lieskovsky G (1984) Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol 131:1069–1072
Slack NH, Prout GR (1980) The heterogeneity of invasive bladder cancer carcinoma and different response to treatment. J Urol 123:644–652
Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC, Morse MJ, Whitmore WF (1985) Preliminary results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cis-platin) for transitional cell carcinoma of the urothelium. J Urol 133:403–407
Stoeckle M, Alken P, Jacobi GH, Hohenfellner R (1987) Besitzt die pelvine Lymphadenektomie im Rahmen der radikalen Zystektomie eine therapeutische Bedeutung? 38. Verhandlungsgericht der dt Ges f Urol. Springer, Berlin Heidelberg New York (in press)
Stoeckle M, Alken P, Engelmann U, Jacobi GH, Riedmiller H, Hohenfellner R (1987) Radical cystectomy — often too late? Eur Urol (in press)
Studer UE, Ruchti E, Greiner RM, Zingg EJ (1983) Faktoren, welche die Überlebensrate nach radikaler Zystektomie beeinflussen. Akt Urol 14:70–77
Tanke HJ, Ingen EMv, Ploem JS (1979) Acriflavine-Feulgen Stilbene staining: A procedure for automated cervical cytology with a television based system (LEYTAS). J Histochem Cytochem 27:84–86
Tanke HJ, Ploem JS, Jonas U (1982) Kombinierte Durchflußzytometrie und Bildanalyse zur automatisierten Zytologie von Blasenepithel und Prostata. Akt Urol 13:109–115
Tomasino RM, Orestano F, Morello V (1985) Pathologische Charakteristika des infiltrierenden Blasenkarzinoms mit Bezug zur Metastasierung: Eine vorläufige Auswertung von 59 radikalen Zystektomiepräparaten. Akt Urol 16:218–221
Vindelov LL, Christensen IJ, Nissen NI (1983) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323–327
Wallace DM, Bloom HJG (1976) The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report). Br J Urol 48:587–594
Author information
Authors and Affiliations
Additional information
Supported by a grant of the Deutsche Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Stöckle, M., Tanke, H.J., Mesker, W.E. et al. Automated DNA-image cytometry: a prognostic tool in infiltrating bladder carcinoma?. World J Urol 5, 127–132 (1987). https://doi.org/10.1007/BF00327070
Issue Date:
DOI: https://doi.org/10.1007/BF00327070